-
Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE
-
Real-World Safety and Effectiveness of Lasmiditan in Patients with Migraine: A Post-Marketing Observational Study in Japan
-
Elevated functional magnetic resonance imaging activity in cognitively normal participants predicts future dementia
-
Spectral Composition of Ambient White Light Modulates Photophobia and Headache Intensity During Migraine Attacks
-
Changes in Migraine-Related Outcomes and Functioning at 1 Year: Results of the Longitudinal OVERCOME (US) Study
-
Comparative Efficacy and Acceptability of Noninvasive Brain Stimulation for Migraine: A Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials
-
Patient Experience with 10 mg Intranasally Administered Zavegepant as an Acute Treatment of Migraine Attacks: Qualitative Research Findings
-
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
-
Correction: Real‑World Response and Super‑Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
-
The Burden of Epilepsy in Thailand: Estimating Societal Costs and Quality of Life
-
Quality of Life After Psychosis: Surviving Schizophrenia and Making a Full Emotional Recovery
-
Multidomain Fatigue, Cognitive, and Quality of Life Observations in Generalized Myasthenia Gravis Under Ravulizumab: A Case Series
-
Symptom Networks and Associations with Quality of Life in Patients with Early to Mid-Stage Parkinson’s Disease: A Network Analysis
-
Neuropsychiatric Clues to Herpes Simplex Virus Encephalitis Presenting as Normal Pressure Hydrocephalus
-
Managing fatigue in patients with Parkinson's disease: a patient-focused perspective
-
Progressive Muscle Relaxation Therapy in Epilepsy Management: Its Influence on Stress, Fatigue, and Quality of Life
-
Factors Associated with Poor Health-Related Quality of Life Among Patients with Epilepsy at Mulago National Referral Hospital
-
Trajectories of quality of life, anxiety and depressive symptomatology, and health‐related work productivity after first seizure events
-
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication Satisfaction
-
How to measure the impact of the COVID-19 pandemic on quality of life: COV19-QoL – the development, reliability and validity of a new scale
-
Personalized tremor control targeting for MR-guided focused ultrasound using tractography
-
Parkinson's disease treatments: focus on transcranial direct current stimulation (tDCS)
-
Oral Health-Related Quality of Life and Depression in Patients with Schizophrenia: The Mediating Roles of Oral Health Literacy and Oral Health-Related Self-Efficacy in a Cross-Sectional Structural Equation Analysis
-
Life-threatening arrhythmias in children with elevated intracranial pressure: a case series and ...
